$88.01
+
$0.48 (0.55%)
End-of-day quote: 04/22/2024
NasdaqGS:BNTX
BioNTech Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $149.56 | $174.55 | 0.00% | 3 | $356.43B |
| MRK | Merck | NYSE | Outperform | $126.88 | $130.51 | 0.00% | 11 | $318.60B |
| AZN | AstraZeneca PLC | LSE | Outperform | £112.68 | £165.99 | 0.00% | 16 | £169.69B |
| PFE | Pfizer | NYSE | Outperform | $26.32 | $32.87 | 0.00% | 6 | $147.23B |
| SAN | Sanofi | ENXTPA | Outperform | 88.85€ | 102.80€ | 0.00% | 9 | 108.49€B |
| GSK | GSK | LSE | Outperform | £16.51 | £17.30 | 0.00% | 12 | £65.34B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.12k | ¥4.74k | 0.00% | 0 | ¥6.38T |
| LONN | Lonza Group | SWX | Buy | CHF526.40 | CHF516.89 | 0.00% | 8 | CHF36.26B |
| MRNA | Moderna | NasdaqGS | Outperform | $107.89 | $135.42 | 0.00% | 1 | $38.83B |
| VLA | Valneva | ENXTPA | Outperform | 3.72€ | 10.03€ | 0.00% | 0 | 528.64€M |
| NVAX | Novavax | NasdaqGS | Outperform | $4.19 | $23.25 | 0.00% | 4 | $555.61M |
| CVAC | CureVac N.V. | NasdaqGM | Outperform | $2.60 | $12.92 | 0.00% | 1 | $546.37M |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.61 | $6.00 | 0.00% | 0 | $18.02M |
